Abstract:Introduction: Itch is a common symptom of many skin and systemic diseases. Identifying novel endogenous itch mediators and the downstream signaling pathways involved will contribute to the development of new strategies for the treatment of chronic itch. In the present study, we adopted behavioral testing, patch clamp recording and metabonomics analysis to investigate the role of agmatine in itch and the underlying mechanism. Methods: Behavioral analysis was used to evaluate the establishing of acute and chronic itch mice model, and to test the effects of different drugs or agents on mice itch behavior. Western blotting analysis was used to test the effect of agmatine on phosphorylation of ERK (p-ERK) expression in the spinal cord. Patch clamp recording was used to determine the effect agmatine on the excitability of DRG neurons and the role of ASIC3. Finally, the metabonomics analysis was performed to detect the concentration of agmatine in the affected skin under atopic dermatitis or psoriasis conditions. Results: We fused a mouse model and found that an intradermal injection of agmatine (an endogenous polyamine) into the nape of the neck or cheek induced histamine-independent scratching behavior in a dose-dependent manner. In addition, the ablation of nociceptive C-fibers by resiniferatoxin (RTX) abolished agmatine-induced scratching behavior. However, agmatine-induced itch was not affected by the pharmacological inhibition of either transient receptor potential vanilloid 1 (TRPV1) or transient receptor potential ankyrin 1 (TRPA1); similar results were obtained from TRPV1 −/− or TRPA1 −/− mice. Furthermore, agmatine-induced itch was significantly suppressed by the administration of acid-sensing ion channel 3 (ASIC3) inhibitors, APETx2 or amiloride. Agmatine also induced the upregulation of p-ERK in the spinal cord; this effect was inhibited by amiloride. Current clamp recording showed that the acute perfusion of agmatine reduced the rheobase and increased the number of evoked action potentials in acute dissociated dorsal root ganglion (DRG) neurons while amiloride reversed agmatine-induced neuronal hyperexcitability. Finally, we identified significantly higher levels of agmatine in the affected skin of a mouse model of atopic dermatitis (AD) when compared to controls, and the scratching behavior of AD mice was significantly attenuated by blocking ASIC3. Discussion: Collectively, these results provide evidence that agmatine is a novel mediator of itch and induces itch via the activation of ASIC3. Targeting neuronal ASIC3 signaling may represent a novel strategy for the treatment of itch.

CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis

Chemokine Receptor CXCR3 in the Spinal Cord Contributes to Chronic Itch in Mice

TLR3 Deficiency Impairs Spinal Cord Synaptic Transmission, Central Sensitization, and Pruritus in Mice.

Sensory neuron–expressed TRPC3 mediates acute and chronic itch

Sensory TRP channels contribute differentially to skin inflammation and persistent itch

Enhanced Scratching Elicited by a Pruritogen and an Algogen in a Mouse Model of Contact Hypersensitivity.

Toll-Like Receptor 4 Contributes to Chronic Itch, Alloknesis, and Spinal Astrocyte Activation in Male Mice

Vascular Endothelial Growth Factor a Promotes Chronic Itch via VEGFA-VEGFR2-PI3K-TRPV1 Axis in Allergic Contact Dermatitis

20-HETE mediated TRPV1 activation drives allokinesis via MrgprA3 + neurons in chronic dermatitis

Altered Expression of Itch‑related Mediators in the Lower Cervical Spinal Cord in Mouse Models of Two Types of Chronic Itch.

Cortical GluK1 Kainate Receptors Modulate Scratching in Adult Mice

Glutamate Acts As a Neurotransmitter for Gastrin Releasing Peptide-Sensitive and Insensitive Itch-Related Synaptic Transmission in Mammalian Spinal Cord

ACC to Dorsal Medial Striatum Inputs Modulate Histaminergic Itch Sensation

S1P/S1PRs-TRPV4 Axis is a Novel Therapeutic Target for Persistent Pain and Itch in Chronic Dermatitis

Differential regulation of pruritic sensation and emotion by cannabinoid type 1 receptors on mPFC glutamatergic and GABAergic neurons

TNF-α/TNFR1 Signaling is Required for the Full Expression of Acute and Chronic Itch in Mice Via Peripheral and Central Mechanisms.

Cytokines and Chemokines Modulation of Itch

Acid-sensing ion channel 3 is required for agmatine-induced histamine-independent itch in mice

Spinal IL-33/ST2 Signaling Mediates Chronic Itch in Mice Through the Astrocytic JAK2-STAT3 Cascade

Baicalein ameliorates chronic itch in ACD mice by suppressing the spinal astrocytic STAT3-LCN2 cascade

Dendritic cells under allergic condition enhance the activation of pruritogen-responsive neurons via inducing itch receptors in a co-culture study